Dean J. Mitchell

Insider Reports History

Location
C/O Bristol Myers Squibb Co, 345 Park Ave, New York, NY
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dean J. Mitchell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. Director Ordinary Shares 91.2K $889K $9.75 May 19, 2025 Direct
Praxis Precision Medicines, Inc. Director Common Stock 17.3K $760K $44.04 Sep 24, 2025 Direct
PRECIGEN, INC. Director Common Stock 503K $720K $1.43 Mar 14, 2024 Direct
PRECIGEN, INC. Director Restricted Stock Units 87.4K $125K $1.43 Mar 14, 2024 Direct
ImmunoGen, Inc. Director Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 102K Mar 14, 2024 Direct
Theravance Biopharma, Inc. Director Share Option (Right to Buy) 24.3K May 19, 2025 Direct
Praxis Precision Medicines, Inc. Director Stock Option (Right to Buy) 8.77K Sep 24, 2025 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 $5.19 Feb 12, 2024 Direct
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 Apr 3, 2024 Direct

Insider Reports Filed by Dean J. Mitchell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRAX Praxis Precision Medicines, Inc. Sep 24, 2025 6 $484K 4 Sep 25, 2025 Director
PRAX Praxis Precision Medicines, Inc. Jun 26, 2025 1 $0 4 Jun 27, 2025 Director
TBPH Theravance Biopharma, Inc. May 19, 2025 2 $0 4 May 21, 2025 Director
PRAX Praxis Precision Medicines, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
TBPH Theravance Biopharma, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
KNTE Kinnate Biopharma Inc. Apr 3, 2024 4 $0 4 Apr 5, 2024 Director
PGEN PRECIGEN, INC. Mar 14, 2024 3 $56.5K 4 Mar 18, 2024 Director
PGEN PRECIGEN, INC. Mar 9, 2024 2 $0 4 Mar 12, 2024 Director
IMGN ImmunoGen, Inc. Feb 12, 2024 9 $0 4 Feb 12, 2024 Director
IMGN ImmunoGen, Inc. Sep 22, 2023 1 $147K 4/A Dec 19, 2023 Director
IMGN ImmunoGen, Inc. Sep 22, 2023 2 $147K 4 Sep 26, 2023 Director
PGEN PRECIGEN, INC. Sep 22, 2023 1 $35.3K 4 Sep 25, 2023 Director
IMGN ImmunoGen, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
PRAX Praxis Precision Medicines, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
KNTE Kinnate Biopharma Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
TBPH Theravance Biopharma, Inc. May 2, 2023 2 $0 4 May 4, 2023 Director
PRAX Praxis Precision Medicines, Inc. Mar 24, 2023 1 $41.8K 4 Mar 27, 2023 Director
PGEN PRECIGEN, INC. Mar 9, 2023 3 $56.5K 4 Mar 13, 2023 Director
PGEN PRECIGEN, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
IMGN ImmunoGen, Inc. Dec 30, 2022 1 $0 4 Jan 4, 2023 Director
IMGN ImmunoGen, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director
IMGN ImmunoGen, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director
IMGN ImmunoGen, Inc. Jun 15, 2022 2 $148K 4 Jun 17, 2022 Director
KNTE Kinnate Biopharma Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
PRAX Praxis Precision Medicines, Inc. Jun 8, 2022 1 $45.2K 4 Jun 9, 2022 Director
PRAX Praxis Precision Medicines, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
TBPH Theravance Biopharma, Inc. Apr 26, 2022 2 $0 4 Apr 28, 2022 Director
IMGN ImmunoGen, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
PGEN PRECIGEN, INC. Mar 25, 2022 2 $0 4 Mar 29, 2022 Director
PGEN PRECIGEN, INC. Feb 22, 2022 3 $56.5K 4 Feb 24, 2022 Director
IMGN ImmunoGen, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director
IMGN ImmunoGen, Inc. Sep 30, 2021 1 $0 4 Oct 1, 2021 Director
IMGN ImmunoGen, Inc. Sep 3, 2021 8 $0 4 Sep 3, 2021 Director
IMGN ImmunoGen, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
IMGN ImmunoGen, Inc. Jun 16, 2021 2 $298K 4 Jun 17, 2021 Director
KNTE Kinnate Biopharma Inc. Jun 11, 2021 1 $0 4 Jun 14, 2021 Director
PRAX Praxis Precision Medicines, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director